In 2016, a recent business graduate entered the workforce as the manager of a radio station in a small town. His new employer, RSM Broadcasting, led the way in serving small Canadian communities and took steps to provide radio content in the most relevant way possible, but it might be time to quicken the pace. He faced a number of obstacles because the industry had been changing and internal politics made it challenging to enact any of his own ideas for strategic renewal. He had three options: support a current initiative, bolster his own idea for change, or focus on his own development. His newness to the organization, his youth, and his position as a middle manager could get in the way of promoting change in the short-term.
In the spring of 2015, a marketing professor from Indore City in India was looking for an academic, entrepreneurial opportunity that would allow him to work alongside his wife. The professor came across a franchise proposal for a preschool with Delhi-based Wonder Kidz Education Pvt. Ltd. The total investment in the project would be approximately ₹625,000, and cash profits would come in the first year. After discussing the opportunity with the company's director, the professor was interested in taking on the franchise. However, not being an expert in finance, he was confused about the calculations and decided to seek an opinion on the financial feasibility of the project before making his decision.
In 2014, the Patient Room of the Future (PRoF) was the largest European open innovation consortium in the healthcare sector. Established in 2009 by a group of manufacturers who were suppliers to the health care sector, PRoF brought more than 300 professionals from multiple disciplines and industries together to think about and contribute to the future of the health care industry. The consortium derived its power from a novel interdisciplinary approach, resulting in the successful completion of four projects. Yet its future presented many unanswered questions: How would PRoF continue to provide an innovative and dynamic environment for its members and stakeholders in the healthcare sector? How would PRoF's projects achieve large-scale adoption, and what resources were needed to do that? What was the next step in the consortium's development?
In 2012, Germany-based Putzmeister was acquired by China-based SANY, the largest concrete machinery manufacturer in the world. By early 2015, the degree and extent of integration was still incomplete, which put pressure on SANY's management. SANY focused mainly on the Chinese domestic market, whereas Putzmeister had an established brand and good experience in international markets. Should the acquisition integration focus only on Putzmeister, or should it be tied more closely to SANY's strategic renewal? SANY and Putzmeister had launched a "double-brand strategy" in specific markets, but was it the appropriate strategy?
In mid-2015, a credit analyst with a leading investment company was tasked with assessing the overall credit quality of a chemical company that equity analysts had recommended as a long-term investment for his firm's insurance equity fund. The analyst set out to use various financial parameters-liquidity, working capital, profitability, efficiency, capital structure, and debt servicing. He believed that a fair assessment of credit quality could help capture a firm's financial health in its entirety, and had a lot to consider as he began his analysis. The case illustrates best practices for credit analysts in assessing a target company's overall financial risk profile using the company's publicly available audited financial statements.
In January 2016, the chief executive officer of Apollo Gleneagles Hospitals (AGH) was reflecting on the 12-year journey that had led to the establishment of AGH as the strongest pillar of holistic healthcare in Eastern India. AGH brought together the best infrastructure, equipment, people, and systems to serve the people of Eastern India with end-to-end tertiary healthcare. The institution grew with a continuous drive for expanding knowledge, introducing the latest technologies, and building a culture of compassion and care. However, AGH's success had led to a shift in focus, drawing the attention of several leading tertiary care hospitals to the untapped healthcare delivery potential in Eastern India. This shift meant increased competition for AGH and higher expectations from its customers. AGH wanted to maintain its leadership position and better understand the organization's future challenges and focus areas. Which business model would best serve the people of India: expanding the current location or launching a multi-location facility? How could AGH maintain its current high level of recognition, expertise, and availability?
Researchers at the Ontario Veterinary College had formed a company, Immuno-Genetics Inc., to develop new technologies to measure the immune response of dairy cows by using a blood test and skin thickness test on individual cows. Cows who showed a high immune response were unlikely to contract a number of common diseases. The test results thus allowed dairy producers to determine the likelihood of cows having health problems over their lifetimes. This information was valuable in managing a dairy herd to optimize performance and minimize health costs. Immuno-Genetics' early marketing research supported the launch of the technology, but an effective marketing strategy had to be developed. Immuno-Genetics had to determine who should be targeted, what products should be sold to each target, how the products should be priced, and what method of distribution to use. In addition, a promotional strategy needed to be developed for the product launch, and sales and profit projections needed to be made for the first two years of operations.
"CVS Health: Redefining the Value Proposition" explores how a company can use shared value as a lens to think about competition and strategy choices in a challenging and evolving industry. The case takes a historical look at the structure of the retail pharmacy industry and the changing nature of rivalry among competitors. The case examines how CVS was able to surpass the long-time industry leader, Walgreens, and highlights CVS Health's shift in strategy starting in the mid-2000s.
Evan Siddall, newly appointed CEO of Canada Mortgage Housing Corporation, a governmental organization focused on the residential housing market, is charged with leading change at the organization. The case follows this process of change step by step and looks at the challenges Siddall faces. After two years of leading change Siddall questions: should he continue to push forward with a change agenda? Or should the organization pause and catch its breath?
This module reading begins by describing the three sources of strategic risk - operations risk, asset impairment risk, and competitive risk - and demonstrates how these risks can undermine an entire business. To assist in the identification of these risks, the risk exposure calculator is introduced as a diagnostic tool to assess the pressures created by growth, culture, and information management. Finally, the dangerous triad of pressure, opportunity, and rationalization is discussed and analyzed to understand the conditions under which employees may be tempted to engage in misrepresentation and fraud. While this module is designed to be used alone, it is part of the Strategy Execution series. Taken together, the series forms a complete course that teaches the latest techniques for using performance measurement and control systems to implement strategy. Modules 1 - 4 set out the foundations for strategy implementation. Modules 5 - 10 teach quantitative tools for performance measurement and control. Modules 11 - 15 illustrate the use of these techniques by managers to achieve profit goals and strategies. View the full Strategy Execution series at: hbsp.harvard.edu/strategy-execution.
Describes how Deutsche Bank, a leading bank in Europe, is deciding whether or not to launch a new structured retail product in Germany: an auto callable note. Will this product find a market and how does it fit into the bank's product portfolio? The case investigates how Deutsche Bank manufactures and distributes its structured retail products, and more broadly explores the opportunities and challenges of offering financial products to households. The case also dwells on the scale and scope of business of retail banking in an increasingly regulated environment.
The High-Impact Wealth Management case series is a portfolio of cases that are built around the high-impact theme. Each case in the series can stand on its own to deliver a unique learning objective; but, taken together, the cases are designed to cover all seven topics covered in the list of "common-cents" strategies. Also refer to W16522.
In 2012, the founder of Patanjali Ayurved Limited (PAL) and his associate were leveraging a unique business model by venturing into the fast-moving consumer goods sector in India. By March 2016, PAL had become the fourth-largest company in this highly competitive industry and was planning to become the market leader by 2020. Through its low-priced herbal and Ayurvedic products, PAL occupied a unique white space in the already existing strategic groups of domestic and multinational competitors. Industry experts were undecided about whether PAL posed a serious threat to multinational and domestic firms or if PAL should be praised for creating a new market for its products in India. If PAL was posing a real threat, then other fast-moving consumer goods firms had to develop strategies to maintain their own position, and PAL needed a plan to face the challenges involved in its future growth.
Xiaomi, the Chinese smartphone company founded in 2010, had quickly become an industry leader in the Chinese market. By 2016 it had started to expand internationally, and this case lays out the company's globalization strategies and challenges moving forward. Hugo Barra, a top Android executive, had left Google a few years earlier to lead Xiaomi's international growth. Xiaomi's founder and CEO, Lei Jun, said the company's ultimate goal was "making good but cheap things," a low pricing strategy that had succeeded in China. The company sold over 70 million mobile phones in 2015-while aggressively building out a robust ecosystem. However, Xiaomi had expected to sell 80 to 100 million units that year; it was facing a declining domestic market and increased competition. Therefore, international expansion had become an important part of the company's overall strategy. But expanding to other countries would be a challenging road. For one, it would take considerable time and effort to tailor the company's Android-based MIUI operating system for diversified markets-and obtain market-access qualifications. Xiaomi's patent portfolio was thin compared to those of large competitors, and it ran the risk of lawsuits from companies that held patent rights in the countries it wanted to enter. Other challenges included building out sales channels, output capacity, and cross-culture management development. Xiaomi's international plan included ten countries in Asia, Europe, and Latin America. The next year or two would be critical for Xiaomi-and it needed to make the right strategic decisions to succeed in its globalization efforts.